keyword
https://read.qxmd.com/read/38655689/dendritic-cell-subpopulations-in-carcinoma-ex-pleomorphic-adenoma-a-multicenter-study
#21
JOURNAL ARTICLE
Bárbara Azevedo Machado, Ana Guadalupe Gama-Cuellar, João Scarini, Katya Pulido Díaz, Fernanda Viviane Mariano, Ricardo Luiz Cavalcanti Albuquerque-Junior, Rogério Gondak
OBJECTIVE: Carcinoma ex-pleomorphic adenoma (CEXPA) represents a malignant transformation from a recurrent or primary pleomorphic adenoma (PA), and the immune response may be essential in this process. Therefore, in this study, we aimed to identify and quantify subpopulations of dendritic cells (DCs) in CEXPA, residual PA in CEXPA (rPA), and PA. MATERIALS AND METHODS: A multicenter study was performed collecting salivary gland tumor (SGT) samples from three Oral and Maxillofacial Pathology Centers...
April 24, 2024: Oral Diseases
https://read.qxmd.com/read/38655493/microsatellite-instability-and-mismatch-repair-protein-deficiency-equal-predictive-markers
#22
REVIEW
Maja L Nádorvári, Gábor Lotz, Janina Kulka, András Kiss, József Tímár
Current clinical guidelines recommend mismatch repair (MMR) protein immunohistochemistry (IHC) or molecular microsatellite instability (MSI) tests as predictive markers of immunotherapies. Most of the pathological guidelines consider MMR protein IHC as the gold standard test to identify cancers with MMR deficiency and recommend molecular MSI tests only in special circumstances or to screen for Lynch syndrome. However, there are data in the literature which suggest that the two test types may not be equal. For example, molecular epidemiology studies reported different rates of deficient MMR (dMMR) and MSI in various cancer types...
2024: Pathology Oncology Research: POR
https://read.qxmd.com/read/38655385/the-extracellular-vesicles-in-hiv-infection-and-progression-mechanisms-and-theranostic-implications
#23
REVIEW
Zhen Tang, Yao Lu, Jiu-Long Dong, Wen Wu, Jian Li
Extracellular vesicles (EVs), these minute yet mighty cellular messengers are redefining our understanding of a spectrum of diseases, from cancer to cardiovascular ailments, neurodegenerative disorders, and even infectious diseases like HIV. Central to cellular communication, EVs emerge as both potent facilitators and insightful biomarkers in immune response and the trajectory of disease progression. This review ventures deep into the realm of EVs in HIV-unraveling their pivotal roles in diagnosis, disease mechanism unravelling, and therapeutic innovation...
2024: Frontiers in Bioengineering and Biotechnology
https://read.qxmd.com/read/38655365/pan-cancer-analysis-of-slc2a-family-genes-as-prognostic-biomarkers-and-therapeutic-targets
#24
JOURNAL ARTICLE
Yating Liu, Xinyu Li, Jie Yang, Shanshan Chen, Changyu Zhu, Yijun Shi, Shoutao Dang, Weitao Zhang, Wei Li
BACKGROUND: The major facilitator superfamily glucose transporters (GLUTs), encoded by solute carrier 2A (SLC2A) genes, mediate the transmembrane movement and uptake of glucose. To satisfy the improved energy demands, glycolysis flux is increased in cancers compared with healthy tissues. Multiple diseases, including cancer, have been associated with GLUTs. Nevertheless, not much research has been done on the functions of SLC2As in pan-cancer prognosis or their clinical treatment potential...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38655340/microbiome-profiling-and-co-metabolism-pathway-analysis-in-cervical-cancer-patients-with-acute-radiation-enteritis
#25
JOURNAL ARTICLE
Chen-Ying Ma, Jing Zhao, Ju-Ying Zhou
BACKGROUND: Intestinal bacteria significantly contribute to the metabolism of intestinal epithelial tissues. As the occurrence and development of radiation enteritis (RE) depend on the "co-metabolism" microenvironment formed by the host and intestinal microbiota, which involves complex influencing factors and strong correlations, ordinary techniques struggle to fully explain the underlying mechanisms. However, given that it is based on systems biology, metabolomics analysis is well-suited to address these issues...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38655323/identification-of-aldob-as-a-novel-prognostic-biomarker-in-kidney-clear-cell-renal-cell-carcinoma
#26
JOURNAL ARTICLE
Xiao-Yang Li, You-Yao Xu, Sen-Yan Wu, Xi-Xi Zeng, Yan Zhou, Guo-Bin Cheng
Kidney clear cell renal cell carcinoma (KIRC) is also the most lethal subtype among all kidney cancer subtypes, posing a severe threat to public health. Therefore, it is crucial to identify new, reliable biomarkers in KIRC. Therefore, it is crucial to identify novel, reliable biomarkers associated with KIRC. We analyzed RNA sequence results from TCGA and several GEO datasets. The commonly deregulated gene, ALDOB, was found in multiple data and confirmed its important prognostic value. Subsequently, we explored the specific mechanism by which ALDOB regulates anti-tumor immunity through in vivo and in vitro experiments...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38655266/slc7a11-inhibits-ferroptosis-and-downregulates-pd-l1-levels-in-lung-adenocarcinoma
#27
JOURNAL ARTICLE
Zhenyao Huang, Xia Chen, Yun Wang, Jiali Yuan, Jing Li, Wenlu Hang, Hao Meng
INTRODUCTION: Lung adenocarcinoma (LUAD) is a prevalent form of lung cancer originating from lung glandular cells with low survival rates despite recent therapeutic advances due to its diverse and complex nature. Recent evidence suggests a link between ferroptosis and the effectiveness of anti-PD-L1 therapy, with potential synergistic effects. METHODS: Our study comprehensively analyzed the expression patterns of ferroptosis regulators in LUAD and their association with prognosis and PD-L1 expression...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38655260/mechanisms-of-resistance-to-targeted-therapy-and-immunotherapy-in-non-small-cell-lung-cancer-promising-strategies-to-overcoming-challenges
#28
REVIEW
Yuchu Xiang, Xudong Liu, Yifan Wang, Dawei Zheng, Qiuxing Meng, Lingling Jiang, Sha Yang, Sijia Zhang, Xin Zhang, Yan Liu, Bo Wang
Resistance to targeted therapy and immunotherapy in non-small cell lung cancer (NSCLC) is a significant challenge in the treatment of this disease. The mechanisms of resistance are multifactorial and include molecular target alterations and activation of alternative pathways, tumor heterogeneity and tumor microenvironment change, immune evasion, and immunosuppression. Promising strategies for overcoming resistance include the development of combination therapies, understanding the resistance mechanisms to better use novel drug targets, the identification of biomarkers, the modulation of the tumor microenvironment and so on...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38655066/transcriptomic-profile-of-premature-ovarian-insufficiency-with-rna-sequencing
#29
JOURNAL ARTICLE
Jiaman Wu, Shiyu Feng, Yan Luo, Yan Ning, Pingping Qiu, Yanting Lin, Fei Ma, Yuanyuan Zhuo
INTRODUCTION: This study aimed to explore the transcriptomic profile of premature ovarian insufficiency (POI) by investigating alterations in gene expression. METHODS: A total of sixty-one women, comprising 31 individuals with POI in the POI group and 30 healthy women in the control group (HC group), aged between 24 and 40 years, were recruited for this study. The transcriptomic profiles of peripheral blood samples from all study subjects were analyzed using RNA-sequencing...
2024: Frontiers in Cell and Developmental Biology
https://read.qxmd.com/read/38655053/linc01614-is-a-promising-diagnostic-and-prognostic-marker-in-hnsc-linked-to-the-tumor-microenvironment-and-oncogenic-function
#30
JOURNAL ARTICLE
Xiong Tian, Dali Hu, Na Wang, Lele Zhang, Xuequan Wang
BACKGROUND: Tumor initiation and metastasis influence tumor immune exclusion and immunosuppression. Long non-coding RNA (lncRNA) LINC01614 is associated with the prognosis and metastasis of several cancers. However, the relationship between LINC01614 and cancer immune infiltration and the biofunction of LINC01614 in head and neck squamous cell carcinoma (HNSC) remain unclear. METHODS: The Genotype-Tissue Expression (GTEx) and The Cancer Genome Atlas (TCGA) datasets were used to analyze the expression difference and diagnostic value of LINC01614 in normal and tumor tissues...
2024: Frontiers in Genetics
https://read.qxmd.com/read/38655051/editorial-lung-adenocarcinoma-from-genomics-to-immunotherapy
#31
EDITORIAL
Yiming Meng, Maria Palmieri, Elisa Frullanti
No abstract text is available yet for this article.
2024: Frontiers in Genetics
https://read.qxmd.com/read/38654363/unravelling-driver-genes-as-potential-therapeutic-targets-in-ovarian-cancer-via-integrated-bioinformatics-approach
#32
JOURNAL ARTICLE
Anam Beg, Rafat Parveen, Hassan Fouad, M E Yahia, Azza S Hassanein
Target-driven cancer therapy is a notable advancement in precision oncology that has been accompanied by substantial medical accomplishments. Ovarian cancer is a highly frequent neoplasm in women and exhibits significant genomic and clinical heterogeneity. In a previous publication, we presented an extensive bioinformatics study aimed at identifying specific biomarkers associated with ovarian cancer. The findings of the network analysis indicate the presence of a cluster of nine dysregulated hub genes that exhibited significance in the underlying biological processes and contributed to the initiation of ovarian cancer...
April 23, 2024: Journal of Ovarian Research
https://read.qxmd.com/read/38654325/tumor-suppressive-mir-4732-3p-is-sorted-into-fucosylated-exosome-by-hnrnpk-to-avoid-the-inhibition-of-lung-cancer-progression
#33
JOURNAL ARTICLE
Wanzhen Zhuang, Chengxiu Liu, Yilin Hong, Yue Zheng, Minjian Huang, Haijun Tang, Lilan Zhao, Zhixin Huang, Mingshu Tu, Lili Yu, Jianlin Chen, Yi Zhang, Xiongfeng Chen, Fan Lin, Qi Gao, Chundong Yu, Yi Huang
BACKGROUND: Aberrant fucosylation observed in cancer cells contributes to an augmented release of fucosylated exosomes into the bloodstream, where miRNAs including miR-4732-3p hold promise as potential tumor biomarkers in our pilot study. However, the mechanisms underlying the sorting of miR-4732-3p into fucosylated exosomes during lung cancer progression remain poorly understood. METHODS: A fucose-captured strategy based on lentil lectin-magnetic beads was utilized to isolate fucosylated exosomes and evaluate the efficiency for capturing tumor-derived exosomes using nanoparticle tracking analysis (NTA)...
April 23, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38654319/approaches-to-prevention-of-gynecological-malignancies
#34
REVIEW
Federico Ferrari, Andrea Giannini
Gynecological malignancies represent one of the prevalent diseases in the female sex and prevention is essential to limit their incidence and mortality. Nowadays, not all malignancies benefit from adequate screening methods for this reason new biomarkers and methods are being developed to undertake timely and effective therapies.
April 23, 2024: BMC Women's Health
https://read.qxmd.com/read/38654290/identification-and-validation-of-a-novel-predictive-signature-based-on-hepatocyte-specific-genes-in-hepatocellular-carcinoma-by-integrated-analysis-of-single-cell-and-bulk-rna-sequencing
#35
JOURNAL ARTICLE
Yujian He, Wei Qi, Xiaoli Xie, Huiqing Jiang
BACKGROUND: Hepatocellular carcinoma represents a significant global burden in terms of cancer-related mortality, posing a substantial risk to human health. Despite the availability of various treatment modalities, the overall survival rates for patients with hepatocellular carcinoma remain suboptimal. The objective of this study was to explore the potential of novel biomarkers and to establish a novel predictive signature utilizing multiple transcriptome profiles. METHODS: The GSE115469 and CNP0000650 cohorts were utilized for single cell analysis and gene identification...
April 23, 2024: BMC Medical Genomics
https://read.qxmd.com/read/38654280/expression-of-stat3-and-hypoxia-markers-in-long-term-surviving-malignant-glioma-patients
#36
JOURNAL ARTICLE
Katerina Dvorakova, Veronika Skarkova, Barbora Vitovcova, Jiri Soukup, Hana Vosmikova, Zuzana Pleskacova, Adam Skarka, Michael Christian Bartos, Petr Krupa, Petra Kasparova, Jiri Petera, Emil Rudolf
BACKGROUND: Glioblastoma is a malignant and aggressive type of central nevous system malignancy characterized by many distinct biological features including extensive hypoxia. Hypoxia in glioblatoma associates with complex signaling patterns including activation of several pathways such as MAPK, PI3K-AKT/mTOR and IL-6/JAK/STAT3 with the master regulator HIF-1, which in turn drive particular tumor behaviors determining, in the end, treatment outcomes and patients fate. Thus, the present study was designed to investigate the expression of selected hypoxia related factors including STAT3 in a small set of long-term surviving glioma patients...
April 23, 2024: BMC Cancer
https://read.qxmd.com/read/38654239/a-novel-tcga-validated-programmed-cell-death-related-signature-of-ovarian-cancer
#37
JOURNAL ARTICLE
Xintong Cai, Jie Lin, Li Liu, Jianfeng Zheng, Qinying Liu, Liyan Ji, Yang Sun
BACKGROUND: Ovarian cancer (OC) is a gynecological malignancy tumor with high recurrence and mortality rates. Programmed cell death (PCD) is an essential regulator in cancer metabolism, whose functions are still unknown in OC. Therefore, it is vital to determine the prognostic value and therapy response of PCD-related genes in OC. METHODS: By mining The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx) and Genecards databases, we constructed a prognostic PCD-related genes model and performed Kaplan-Meier (K-M) analysis and Receiver Operating Characteristic (ROC) curve for its predictive ability...
April 23, 2024: BMC Cancer
https://read.qxmd.com/read/38654232/effect-of-glycotoxicity-and-lipotoxicity-on-carbohydrate-antigen-19%C3%A2-%C3%A2-9-in-the-patients-with-diabetes
#38
JOURNAL ARTICLE
Xi-Yu Liu, Xiao-Hong Wang
OBJECTIVES: In comparison to the subjects without diabetes, a greater concentration of serum carbohydrate antigen 19 - 9 (CA 19 - 9) was observed in the subjects with diabetes. Nevertheless, since the occurrence of abnormal CA 19 - 9 is not widespread among the whole diabetic population, this phenomenon has not attracted enough attention. The prevalence of abnormal CA 19 - 9 in hospitalized patients with diabetes was the focus of our research...
April 24, 2024: BMC Endocrine Disorders
https://read.qxmd.com/read/38654221/identification-of-bgn-positive-fibroblasts-as-a-driving-factor-for-colorectal-cancer-and-development-of-its-related-prognostic-model-combined-with-machine-learning
#39
JOURNAL ARTICLE
Shangshang Hu, Qianni Xiao, Rui Gao, Jian Qin, Junjie Nie, Yuhan Chen, Jinwei Lou, Muzi Ding, Yuqin Pan, Shukui Wang
BACKGROUND: Numerous studies have indicated that cancer-associated fibroblasts (CAFs) play a crucial role in the progression of colorectal cancer (CRC). However, there are still many unknowns regarding the exact role of CAF subtypes in CRC. METHODS: The data for this study were obtained from bulk, single-cell, and spatial transcriptomic sequencing data. Bioinformatics analysis, in vitro experiments, and machine learning methods were employed to investigate the functional characteristics of CAF subtypes and construct prognostic models...
April 23, 2024: BMC Cancer
https://read.qxmd.com/read/38654165/prognostic-analysis-of-hepatocellular-carcinoma-based-on-cuproptosis-associated-lncrnas
#40
JOURNAL ARTICLE
Mingwei Wei, Libai Lu, Zongjiang Luo, Jiasheng Ma, Jianchu Wang
OBJECTIVES: Cuproptosis represents an innovative type of cell death, distinct from apoptosis, driven by copper dependency, yet the involvement of copper apoptosis-associated long non-coding RNAs (CRLncRNAs) in hepatocellular carcinoma (HCC) remains unclear. This study is dedicated to unveiling the role and significance of these copper apoptosis-related lncRNAs within the context of HCC, focusing on their impact on both the development of the disease and its prognosis. METHODS: We conducted an analysis of gene transcriptomic and clinical data for HCC cases by sourcing information from The Cancer Genome Atlas database...
April 23, 2024: BMC Gastroenterology
keyword
keyword
9057
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.